BLZ945
-
Catalog numberB1651-25
-
PricePlease ask
-
Size25 mg
-
-
Alternative_nameBLZ-945, BLZ945; BLZ 945; 4-((2-(((1R,2R)-2-hydroxycyclohexyl)amino)benzo[d]thiazol-6-yl)oxy)-N-methylpicolinamide; 4-[[2-[[(1R,2R)-2-hydroxycyclohexyl]amino]-1,3-benzothiazol-6-yl]oxy]-N-methylpyridine-2-carboxamide
-
DescriptionBLZ945 is a brain-penetrant CSF-1R kinase inhibitor. The biochemical IC50 for CSF-1R is 1 nM, which is >3200-fold higher than its affinity for other kinases.
-
CAS Number953769-46-5
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₀H₂₂N₄O₃S
-
Molecular Weight398.48
-
Cell PermeableYes
-
Purity>98%
-
SolubilitiesDMSO
-
HandlingProtect from air and light
-
Tag LineA brain-penetrant CSF-1R inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
MDL NumberMFCD28142668
-
PubChem CID46184986
-
SMILESCNC(=O)C1=NC=CC(=C1)OC2=CC3=C(C=C2)N=C(S3)NC4CCCCC4O
-
InChiInChI=1S/C20H22N4O3S/c1-21-19(26)16-10-13(8-9-22-16)27-12-6-7-15-18(11-12)28-20(24-15)23-14-4-2-3-5-17(14)25/h6-11,14,17,25H,2-5H2,1H3,(H,21,26)(H,23,24)/t14-,17-/m1/s1
-
InChi KeyADZBMFGQQWPHMJ-RHSMWYFYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameBLZ945
-
Alternative nameBLZ945
-